A new approach to support specialist prescribing of bDMARDs
Arthritis Australia is part of an eight-member Consortium led by NPS MedicineWise, which is the successful recipient of the ‘Value in Prescribing biological disease-modifying anti-rheumatic drugs (bDMARDs)’ government grant.
The grant will fund a project to improve the use of bDMARDs to ensure the best health and economic outcomes from investment in these therapies.
NPS MedicineWise media release – bDMARDS September 2019 (002)
Discover more...
-
New Report Uncovers Alarming Lack of Research Funding into Our Leading Cause of Disability and Pain
New report recommends Medical Research Future Fund (MRFF) mission for arthritis and musculoskeletal diseases A new Research Australia report released today by Arthritis Australia confirms...
-
Arthritis Australia appoints Chief Executive Officer
MEDIA RELEASE – FOR IMMEDIATE RELEASE3 February 2026 Arthritis Australia today announced the appointment of Louise Hardy as Chief Executive Officer, following her tenure as...
-
Men’s Health Week: Gout is no joke
Gout has a reputation problem. People call it the “disease of kings” or laugh it off as the price of a big weekend. But for...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: